within Pharmacolibrary.Drugs.ATC.J;

model J01DB12
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00012,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DB12</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ceftezole is a first-generation cephalosporin antibiotic. It is primarily used for the treatment of bacterial infections caused by susceptible organisms, such as skin and soft tissue infections, urinary tract infections, and respiratory tract infections. Ceftezole is not a widely used antibiotic today and has largely been replaced by newer-generation cephalosporins in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Ohkawa, M, &amp; Kuroda, K (1980). Pharmacokinetics of ceftezole in patients with normal and impaired renal function. <i>Chemotherapy</i> 26(4) 242–247. DOI:<a href=\"https://doi.org/10.1159/000237912\">10.1159/000237912</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7389424/\">https://pubmed.ncbi.nlm.nih.gov/7389424</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DB12;
